Log in to save to my catalogue

Rubinstein–Taybi syndrome: clinical and molecular overview

Rubinstein–Taybi syndrome: clinical and molecular overview

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68408201

Rubinstein–Taybi syndrome: clinical and molecular overview

About this item

Full title

Rubinstein–Taybi syndrome: clinical and molecular overview

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Expert reviews in molecular medicine, 2007-08, Vol.9 (23), p.1-16

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Rubinstein–Taybi syndrome is characterised by mental retardation, growth retardation and a particular dysmorphology. The syndrome is rare, with a frequency of approximately one affected individual in 100 000 newborns. Mutations in two genes – CREBBP and EP300 – have been identified to cause the syndrome. These two genes show strong homology and enc...

Alternative Titles

Full title

Rubinstein–Taybi syndrome: clinical and molecular overview

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68408201

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68408201

Other Identifiers

ISSN

1462-3994

E-ISSN

1462-3994

DOI

10.1017/S1462399407000415

How to access this item